Skip to content

Upcoming January – April 2013 FDA PDUFA Dates For Orphan Drugs (January 17, 2013 Update)

January 16, 2013
Generic Name Trade Name Sponsor Indication PDUFA Date
Glycerol Phenylbutyrate Ravicti Hyperion    Therapeutics ** Urea Cycle Disorder (UCD) 1/23/13
Mipomersen Sodium Kynamro Genzyme/Isis   Pharmaceuticals Homozygous Familial Hypercholesterolemia (HoFH) 1/29/13
Ampligen Hemispherx BioPharma Chronic Fatigue Syndrome (CFS) 2/02/13
Pomalidomide Celgene Corporation Relapsed refractory multiple myeloma 2/10/13
Regorafenib Stivarga Bayer GastroIntestinal Stromal Tumors (GIST) 2/28/13
Ponatinib Ariad   Pharmaceuticals Chronic Myeloid Leukemia & Acute Lymphoblastic Leukemia 3/27/13
Cysteamine Bitartrate Procysbi Raptor   Pharmaceutical Nephropathic Cystinosis 4/30/13

**Update : Per 01/16/13 Hyperion Therapeutics’ Press Release, FDA has advised them not to expect a final action by the PDUFA date of 01/23/13, because the FDA is “continuing to work on label & post-marketing requirements”.

Please notify at orphandruganaut@gmail.com if any updates are available.

Please note the links for the following 2 chart columns above :

1) “Generic Name” Column Link = Is a source for the FDA PDUFA Date

2) “Indication” Column Link = Is the FDA Orphan Drug Product Designation Database Link

Copyright © 2012-2013, Orphan Druganaut Blog. All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: